Momenta Pharmaceuticals, Inc. (MNTA)

[Boing x 2]

MS News.


"MS News Today ?@MSNewsToday 5h
5 hours ago
Glatiramer acetate 40mg injection site reaction is the most frequent adverse event #MSNewsToday #ECTRIMS2015 “

“A group of researchers are currently tackling the prevalence of Multiple Sclerosis outside Europe and North America, as Prof. David Miller highlighted, “Studies from several parts of the world, in particular some Asian and Arab countries, Iran, Latin America as well as Australia and New Zealand, demonstrate an increase in the prevalence of MS around the world over time.”

Boing X 2